Melanoma

• Science & Technology
• Health & Medicine

NCRI Cancer Conference 2016: Day 4 – liver cancer, obesity, immunotherapy poo predictions and more

Read our final roundup from this year's NCRI Cancer Conference, including how bacteria in the gut could help predict if immunotherapy will work. Read our final roundup from this year's NCRI Cancer Conference, including how bacteria in the gut could help predict if immunotherapy will work.

10 November 2016

• Health & Medicine

Melanoma diagnoses hit 10,000 a year for over 55s

For the first time in the UK, more than 10,000* people aged 55 and over were diagnosed with malignant melanoma in a single year. For the first time in the UK, more than 10,000* people aged 55 and over were diagnosed with malignant melanoma in a single year.

1 July 2016

• Health & Medicine

Combination immunotherapy treatment for melanoma given NHS approval

Melanoma patients in England and Wales are to become the first in Europe to benefit from a powerful combination of immunotherapy drugs. Melanoma patients in England and Wales are to become the first in Europe to benefit from a powerful combination of immunotherapy drugs.

17 June 2016

• Health & Medicine

Studies show continued promise for immunotherapy drugs

Several new immunotherapy drugs are continuing to show benefits across a range of cancer types, according to data presented at a US conference. Several new immunotherapy drugs are continuing to show benefits across a range of cancer types, according to data presented at a US conference.

19 April 2016

• Science & Technology
• Health & Medicine

Gene editing technology could help engineer better cancer targeting immune cells

We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells. We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells.

15 April 2016

• Science & Technology
• Health & Medicine

Blood analysis could offer a real-time ‘snapshot’ of melanoma treatment

We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples. We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples.

15 March 2016

• Science & Technology
• Health & Medicine

Blocking the escape routes: how an HIV drug exposes skin cancer’s weaknesses

A new study from our scientists has found that treating melanoma cells with an HIV drug could make them more sensitive to a 'targeted' cancer drug. A new study from our scientists has found that treating melanoma cells with an HIV drug could make them more sensitive to a 'targeted' cancer drug.

14 March 2016

• Health & Medicine

HIV drug could stop skin cancer becoming drug-resistant

An HIV drug could stop one of the early changes in skin cancer cells that leads to them becoming resistant to treatment. An HIV drug could stop one of the early changes in skin cancer cells that leads to them becoming resistant to treatment.

14 March 2016

• Health & Medicine

Blood test may give early warning of skin cancer relapse

A blood test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing. A blood test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing.

7 March 2016

• Science & Technology
• Health & Medicine

The biggest cancer science stories of 2015

We've enlisted the help of one of our researchers to pick out the biggest cancer research stories of 2015. We've enlisted the help of one of our researchers to pick out the biggest cancer research stories of 2015.

22 December 2015

• Science & Technology
• Health & Medicine

NCRI cancer conference day 2: big data, immunotherapy and prizes

We're back for day two of our highlights from this year's NCRI cancer conference in Liverpool. We're back for day two of our highlights from this year's NCRI cancer conference in Liverpool.

3 November 2015